Menopausal hormone therapy and venous thromboembolism

Menopausal hormone therapy (MHT) is the most effective method of treating vasomotor symptoms and other climacteric symptoms related to estrogen deficiency in peri- and postmenopausal period. In addition to estrogen replacement, women with preserved uterus require the addition of progestagen in order...

Full description

Bibliographic Details
Main Author: Bińkowska, Małgorzata
Format: Online
Language:English
Published: Termedia Publishing House 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520375/
id pubmed-4520375
recordtype oai_dc
spelling pubmed-45203752015-08-31 Menopausal hormone therapy and venous thromboembolism Bińkowska, Małgorzata Featured Paper Menopausal hormone therapy (MHT) is the most effective method of treating vasomotor symptoms and other climacteric symptoms related to estrogen deficiency in peri- and postmenopausal period. In addition to estrogen replacement, women with preserved uterus require the addition of progestagen in order to ensure endometrial safety. Termedia Publishing House 2014-11-02 2014-10 /pmc/articles/PMC4520375/ /pubmed/26327865 http://dx.doi.org/10.5114/pm.2014.46468 Text en Copyright © 2014 Termedia http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Bińkowska, Małgorzata
spellingShingle Bińkowska, Małgorzata
Menopausal hormone therapy and venous thromboembolism
author_facet Bińkowska, Małgorzata
author_sort Bińkowska, Małgorzata
title Menopausal hormone therapy and venous thromboembolism
title_short Menopausal hormone therapy and venous thromboembolism
title_full Menopausal hormone therapy and venous thromboembolism
title_fullStr Menopausal hormone therapy and venous thromboembolism
title_full_unstemmed Menopausal hormone therapy and venous thromboembolism
title_sort menopausal hormone therapy and venous thromboembolism
description Menopausal hormone therapy (MHT) is the most effective method of treating vasomotor symptoms and other climacteric symptoms related to estrogen deficiency in peri- and postmenopausal period. In addition to estrogen replacement, women with preserved uterus require the addition of progestagen in order to ensure endometrial safety.
publisher Termedia Publishing House
publishDate 2014
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520375/
_version_ 1613254220254806016